JB Pharma: Betting big on India Viveka Roychowdhury Jun 6, 2023 Our biggest bet is India and the CDMO space, says Nikhil Chopra, CEO, JB Pharma, taking stock of the company's ongoing transition…
Dawaa Dost becomes maiden Indian startup to raise debt funding under UN SDG-3 EP News Bureau Apr 6, 2022 The company has raised debt funding from Grameen Impact, an "Impact-focussed NBFC" promoted by Grameen Capital
